ORAL LIQUID FORMULATION OF CANAGLIFLOZIN OR ITS PHARMACEUTICALLY ACCEPTABLE SALT THEREOF

The present invention relates to a liquid formulation comprising Canagliflozin or its pharmaceutically acceptable salt with one or more pharmaceutically acceptable excipient, its process for preparation and its application for the treatment of type 2 diabetes mellitus and associated cardiovascular a...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	MUNDADA, Piyush Kishor, ACHLIYA, Girish Shantilal, KAPADIA, Mayur Dilip
Format:	Patent
Sprache:	eng ; fre
Schlagworte:	CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	The present invention relates to a liquid formulation comprising Canagliflozin or its pharmaceutically acceptable salt with one or more pharmaceutically acceptable excipient, its process for preparation and its application for the treatment of type 2 diabetes mellitus and associated cardiovascular and renal complications. La présente invention concerne une formulation liquide comprenant de la canagliflozine ou son sel pharmaceutiquement acceptable avec un ou plusieurs excipients pharmaceutiquement acceptables, son procédé de préparation et son application pour le traitement du diabète sucré de type 2 et des complications cardiovasculaires et rénales associées.